Author:
Hyatt Ana N.,Lake Jordan E.
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Virology
Reference92 articles.
1. Centers for Disease Control and Prevention. National Center for Chronic Disease Prevention and Health Promotion, Division of Nutrition, Physical Activity, and Obesity. Data, Trend and Maps. https://www.cdc.gov/nccdphp/dnpao/data-trends-maps/index.html. Accessed Jun 20, 2022.
2. Lake JE. The fat of the matter: obesity and visceral adiposity in treated HIV infection. Curr HIV/AIDS Rep. 2017;14(6):211–9. https://doi.org/10.1007/s11904-017-0368-6.
3. Godfrey C, Bremer A, Alba D, Apovian C, Koethe JR, Koliwad S, et al. Obesity and fat metabolism in human immunodeficiency virus-infected individuals: immunopathogenic mechanisms and clinical implications. J Infect Dis. 2019;220(3):420–31. https://doi.org/10.1093/infdis/jiz118.
4. Bourgi K, Jenkins CA, Rebeiro PF, Palella F, Moore RD, Altoff KN, et al. Weight gain among treatment-naïve persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada. J Int AIDS Soc. 2020;23(4):e25484. https://doi.org/10.1002/jia2.25484Provides insightful results from a large contemporary observational study.
5. Sahagun SJ, Yeramosu T, Purdy JB, Reynolds JC, Hadigan CM. Associations between central obesity and lifelong antiviral therapy in adults living with HIV acquired from early childhood. J Acquir Immune Defic Syndr. 2022;89(2):208–14. https://doi.org/10.1097/qai.0000000000002841.